Weight-loss drug developer Metsera raises $275 million in US IPO
(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...
Hosted on MSN49m
HIVE Digital Technologies Strengthens Global Strategy with New Advisory Appointment
HIVE Digital Technologies ( ($TSE:HIVE) ) has issued an announcement. HIVE Digital Technologies has announced the appointment of Lieutenant ...